SCHEMBL9818339

SCHEMBL9818339

COc1ccc(/C=C/C(=O)c2ccc(Br)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 10/20 1.00
MAOA P21397 4/20 1.00
F3 P13726 2/20 0.84
MAPT P10636 4/20 0.75
XDH P47989 2/20 0.75
MEN1 O00255 2/20 0.75
ALDH1A1 P00352 2/20 0.75
KMT2A Q03164 2/20 0.75
P4HB P07237 1/20 0.75
CALM1 P0DP23 1/20 0.75
RAB9A P51151 1/20 0.75
NPC1 O15118 1/20 0.73
LMNA P02545 1/20 0.73
CYP1B1 Q16678 3/20 0.72
HSPD1 P10809 1/20 0.72
TNFRSF1A P19438 1/20 0.72
HSPE1 P61604 1/20 0.72
BCHE P06276 1/20 0.72
CYP3A4 P08684 1/20 0.72
NFKB1 P19838 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3469283 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL6323431 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL5058785 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
4,4'-Dimethoxychalcone SCHEMBL978242 0.92 F3 (1.00) MAOBMAOAF3MAPTXDH
4,4'-Dimethoxychalcone SCHEMBL978243 0.92 F3 (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL1659833 0.87 ESR1 (0.86) MAOBMAOAF3MAPTMEN1
SCHEMBL1659832 0.87 ESR1 (0.86) MAOBMAOAF3MAPTMEN1
SCHEMBL1321123 0.86 HDAC3 (0.82) MAOBMAOAF3MAPTXDH
SCHEMBL29040010 0.86 F3 (0.82) MAOBMAOAF3MAPTXDH
SCHEMBL1321125 0.86 HDAC3 (0.82) MAOBMAOAF3MAPTXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220216422-A1 Electroluminescent Device UDC IRELAND LTD (IE) 2022-07-07 US disclosed
US-10941114-B2 Small molecule lipid II inhibitors UNIVERSITY OF MARYLAND, BALTIMORE (US) 2021-03-09 US disclosed
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed
US-20200216394-A1 Small Molecule Lipid II Inhibitors UNIVERSITY OF MARYLAND, BALTIMORE 2020-07-09 US disclosed
WO-2019136147-A1 TOLL-LIKE RECEPTOR SIGNALING INHIBITORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-07-11 WO disclosed
US-9923148-B2 Electroluminescent device UDC IRELAND LIMITED (IE) 2018-03-20 US disclosed
US-9923148-B2 Electroluminescent device UDC IRELAND LIMITED (IE) 2018-03-20 US disclosed
US-20170194568-A9 Electroluminescent Device UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
US-20170194568-A9 Electroluminescent Device UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
US-20160039778-A1 TRPV-1 RECEPTOR ANTAGONIST COMPOUND DERIVED FROM 1,3,4-THIADIAZOLE ALKYLAMIDES AND CHALCONES UNIV CONCEPCION (CL) 2016-02-11 US disclosed
US-20100240892-A1 ELECTROLUMINESCENT DEVICE SCHAEFER THOMAS 2010-09-23 US disclosed
US-20100240892-A1 ELECTROLUMINESCENT DEVICE SCHAEFER THOMAS 2010-09-23 US disclosed
US-20080146574-A1 Heterocycle Substituted Carboxylic Acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2008-06-19 US disclosed
US-20080146574-A1 Heterocycle Substituted Carboxylic Acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2008-06-19 US disclosed
US-7329680-B2 Heterocycle substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2008-02-12 US disclosed
US-7329680-B2 Heterocycle substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2008-02-12 US disclosed
EP-1556360-B1 ELECTROLUMINESCENT DEVICE CIBA SC HOLDING AG (CH) 2008-01-23 EP disclosed
EP-0262672-B1 NON-LINEAR OPTICAL ARTICLE NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1991-11-27 EP disclosed
US-4892681-A BENZALACETOPHENONE DERIVATIVE, RADIATION TRANSPARENT NIPPON OIL AND FATS CO., LTD. (JP) 1990-01-09 US disclosed
EP-0262672-A1 Non-linear optical article NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1988-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216394-A1 Small Molecule Lipid II Inhibitors DBI, FABP2, HDLBP MAOB 4158/4885MAOA 4542/4885F3 1812/4885
US-20160039778-A1 TRPV-1 RECEPTOR ANTAGONIST COMPOUND DERIVED FROM 1,3,4-THIADIAZOLE ALKYLAMIDES AND CHALCONES TRPV1, TRPV3, TRPV2 MAOB 4533/4885MAOA 4359/4885F3 2953/4885
US-10941114-B2 Small molecule lipid II inhibitors DBI, FABP2, SREBF2 MAOB 4357/4885MAOA 4630/4885F3 1924/4885
US-20220216422-A1 Electroluminescent Device PNPO, ODC1, AXL MAOB 82/4885MAOA 172/4885F3 4391/4885
US-20080146574-A1 Heterocycle Substituted Carboxylic Acids PTPRC, PTPRS, PTPRJ MAOB 378/4885MAOA 842/4885F3 2636/4885
US-20170194568-A9 Electroluminescent Device DPYD, PNPO, TYMP MAOB 118/4885MAOA 266/4885F3 4267/4885
US-20100240892-A1 ELECTROLUMINESCENT DEVICE PNPO, ODC1, AXL MAOB 82/4885MAOA 172/4885F3 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.